This review compares how EVs remodel the immune microenvironment in HT, type 2 diabetes mellitus (T2DM), and related disease contexts, with attention to donor cells, cargo, recipient pathways, biomarkers, and therapeutic implications.
Yao Ma, Wei-na Jiang, Tong Zhou et al.· Frontiers in Immunology· 0 citations